Company news, research breakthroughs, and major announcements across industries.

Home/Science

Science |Arcus Biosciences

Arcus Biosciences Announces Commencement of Public Offering of Common Stock

A

Arcus Biosciences, Inc. (NYSE: RCUS), a late clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and immune diseases, today announced that it has commenced an underwritten public offering of its common stock. All of the shares of common stock are being offered by Arcus Biosciences. In addition, Arcus Biosciences intends to grant the underwriters a 30-day option to purchase...

  • PublishedOctober 21, 2026 · 4:22 PM
  • LocationHAYWARD, Calif.
  • IndustryScience
  • LanguageEN

Published by Business Wire. Read the original announcement for the full release.

Read the full announcement →

Latest from leading organizations

Explore recent announcements by organization